Dow Down 0.62% Nasdaq Down 1.14%

Incyte Corporation (INCY)

-NasdaqGS
47.41 Down 1.91(3.87%) Sep 22, 4:00PM EDT
|After Hours : 47.41 0.00 (0.00%) Sep 22, 4:19PM EDT
Prev Close:49.32
Open:49.23
Bid:N/A
Ask:55.11 x 800
1y Target Est:75.15
Beta:0.29
Earnings Date:Oct 31 - Nov 4 (Est.)
Day's Range:46.73 - 49.55
52wk Range:33.01 - 70.86
Volume:1,039,951
Avg Vol (3m):971,197
Market Cap:7.98B
P/E (ttm):N/A
EPS (ttm):-0.65
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for INCY

Comparison

Symbol% ChgMkt Cap
INCYDown 3.87%7.98B
AMGNDown 1.27%108.00B
CELGDown 1.77%73.71B
RHHBYUp 0.07%255.90B

Key Statistics

Forward P/E (1 yr):189.64
P/S (ttm):22.35
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.40
Quarterly EPS Est (Sep-14) :-0.02
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-1.41

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary small molecule drugs primarily for oncology and inflammation. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback